Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 164.00
+1.00 (0.61%)
At close: Jan 21, 2026
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 254.2 billion as of January 21, 2026. Its market cap has increased by 205.66% in one year.
Market Cap
254.20B
Enterprise Value
247.69B
Revenue
34.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
164.00
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 254.20B, an increase of 3,094.10%. That is a compound annual growth rate of 208.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 252.65B | 5.16% |
| Dec 31, 2025 | 240.25B | 154.60% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 33.68B |
| Lin BioScience | 30.73B |
| Lumosa Therapeutics | 29.99B |
| Pell Bio-Med Technology | 26.83B |
| Polaris Group | 24.27B |
| Sunmax Biotechnology | 21.24B |
| EirGenix | 19.06B |
| TaiMed Biologics | 15.85B |